SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-21-010352
Filing Date
2021-02-18
Accepted
2021-02-18 16:53:10
Documents
1
Group Members
VIVO OPPORTUNITY, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea136000-13gvivo8_ternspharm.htm SC 13G 74761
  Complete submission text file 0001213900-21-010352.txt   76237
Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 650 688 0822
Vivo Capital VIII, LLC (Filed by) CIK: 0001618789 (see all company filings)

IRS No.: 471761992 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Subject) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92116 | Film No.: 21650324
SIC: 2834 Pharmaceutical Preparations